Women's Health

>

Latest News

FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth Control July 25, 2024
FDA Approves Femlyv, First Orally Disintegrating Tablet for Birth Control

July 25th 2024

Femlyv (norethindrone acetate and ethinyl estradiol) may expand access to contraception as an option for individuals with swallowing difficulties.

Postpartum Transition Support Increases Primary Care Engagement, Reduces Risk of Readmission / image creidt nursing mother: ©yepifanovahelen/stock.adobe.com
Postpartum Transition Support Increases Primary Care Engagement, Reduces Risk of Readmission

July 23rd 2024

Rising Rates of Diabetes During Pregnancy in Canada Are Not Expected to Slow Down image credit: ©Kletr/stock.adobe.com
Rapid Rise in Rates of Diabetes During Pregnancy in Canada Not Expected to Slow

July 16th 2024

Massachusetts standing orders increase emergency contraceptive access / image credit abortion pill: ©WindyNight/stock.adobe.com
Massachusetts Standing Orders Increase Emergency Contraceptive Access

July 10th 2024

Prenatal RSV VAccine Not Associated with Preterm Birth: Real World Data image credit nursing mother ©yepifanovahelen/stock.adobe.com
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data

July 9th 2024

Latest CME Events & Activities

Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

4th Annual International Congress on the Future of Women’s Health™

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Community Practice Connections™: Leveraging Multidisciplinary Teams in Early-Stage Breast Cancer When the Goal Is Cure

View More

Community Practice Connections®: Evaluating the Evolving Treatment Landscape for mHR+ Breast Cancer-How to Personalize Care and Improve Patient Outcomes

View More

Community Practice Connections™: 22nd Annual International Congress on the Future of Breast Cancer®

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

More News

© 2024 MJH Life Sciences

All rights reserved.